@prefix this: <http://purl.org/np/RAo6wFt6AtZTLC2PJy3nCsWqqetANl-yoiG1EYoHLqn4A> .
@prefix sub: <http://purl.org/np/RAo6wFt6AtZTLC2PJy3nCsWqqetANl-yoiG1EYoHLqn4A#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_11476> bl:category bl:Disease .
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_11476> ;
    rdf:predicate bl:treats ;
    rdf:subject <https://identifiers.org/drugbank:DB11979> ;
    a rdf:Statement ;
    rdfs:label "\"ORILISSA is contraindicated in women:   Who are pregnant  [see Use in Specific Populations ( 8.1 With known osteoporosis because of the risk of further bone loss  [see Warnings and Precautions ( 5.1 With severe hepatic impairment  [see Use in Specific Populations ( 8.7 12.3 With concomitant use of strong organic anion transporting polypeptide (OATP) 1B1 inhibitors (e.g., cyclosporine and gemfibrozil)  [see Drug Interactions ( 7.2   Pregnancy ( 4 Known osteoporosis ( 4 Severe hepatic impairment ( 4 Strong organic anion transporting polypeptide (OATP) 1B1 inhibitors ( 4\"" ;
    bl:provided_by <https://w3id.org/um/NeuroDKG> ;
    bl:relation schema:MedicalContraindication .
  <https://identifiers.org/drugbank:DB11979> bl:category bl:Drug .
}
sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}
sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" ;
    npx:hasSignature "edrHP6jg06G2AtRoWIAYLdQD3o3l/CVCQyOIPCIAYJmN0BiUgLUd0WFNBAcsBI6b4f3GGV8BWr+m/aLmwhOwGQqfOJfoKtBBFHQ7NZCv677fvyW1X1duGwlCYMIgwiFxvCDOfKIUnBm1fTarng5YPnt9cPd7JGLC2gx0yovyEL0=" ;
    npx:hasSignatureTarget this: .
  this: dct:created "2021-08-25T14:03:22.564+02:00"^^xsd:dateTime ;
    dct:creator orcid:0000-0002-1468-3557 ;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM> ;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM> ;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY> .
}